PDSB
PDS Biotechnology Corp
NASDAQ: PDSB · HEALTHCARE · BIOTECHNOLOGY
$1.52
+16.92% today
Updated 2026-10-28
Market cap
$80.45M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.64
Dividend yield
—
52W range
$0 – $2
Volume
31.5M
WallStSmart proprietary scores
18
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C4.5
Quality
C3.0
Profitability
D5.0
Valuation
C+2/9
Piotroski F-Score
Weak
-12.2
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →271 stocks currently score above 75
Price targets
Analyst target
$5.00
+228.95%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy3 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Debt/equity -1.22x — low leverage
Risks
- Piotroski 2/9 — weak financial health
- Altman Z -12.23 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-2.79M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-40.85M | $-42.94M | $-37.61M | $-34.50M | $-9.75M |
| EPS | — | — | — | — | $-0.64 |
| Free cash flow | $-25.71M | $-33.64M | $-35.06M | $-27.75M | $-2.79M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
PDS Biotechnology Corp trades at $1.52. Our Smart Value Score of 18/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -12.23, it sits in the distress.
Frequently asked questions
What is PDS Biotechnology Corp's stock price?
PDS Biotechnology Corp (PDSB) trades at $1.52.
Is PDS Biotechnology Corp overvalued?
PDS Biotechnology Corp carries a Smart Value Score of 18/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of PDS Biotechnology Corp (PDSB)?
The 12-month analyst consensus target is $5.00, about 228.9% above the current $1.52. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
PDS Biotechnology Corp's Altman Z-Score is -12.23, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-856.89%
Beta1.17
50D MA$0.68
200D MA$0.82
Shares out0.07B
Float0.04B
Short ratio—
Avg volume31.5M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—